Ranolazine in Patients With T2DM and Stable Angina
Ranolazine in Patients With T2DM and Stable Angina
Among patients with T2DM, CAD, and persistent chronic angina, despite treatment with up to 2 antianginal agents, ranolazine significantly reduced angina frequency and SL NTG use and was safe and well tolerated.
Conclusions
Among patients with T2DM, CAD, and persistent chronic angina, despite treatment with up to 2 antianginal agents, ranolazine significantly reduced angina frequency and SL NTG use and was safe and well tolerated.
Source...